Axter Therapeutics is a China-based biotech company focusing on developing new medications to serve the domestic and global patient population. At Axter Therapeutics, we bring global drug development standards, experience and resources to the Chinese market. Based on our extensive know-how and precise understanding of both US FDA and China NMPA regulations, we are able to customize development strategies to bring new therapies to China and global markets with maximum speed and efficiency. With our extensive experience in new drug R&D and clinical development worldwide, Axter will be at the cutting edge of global new drug development and registration, and create a highly efficient new drug development platform. We are a gateway from China to the world, and also a gateway from the world to China.